---
schema_version: "secwatch.filing_event.v1"
accession: "0001903596-24-000495"
form_type: "8-K"
ticker: "LUDG"
cik: "0001960262"
company_name: "LUDWIG ENTERPRISES, INC."
filed_at: "2024-08-14T23:59:59+00:00"
generated_at: "2026-05-31T09:27:47.429457+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Ludwig to rename Revealia, plans 2024 launch of cancer screening test

## Summary
- Majority shareholders approved name change to Revealia, Inc., pending FINRA approval.
- Plans to launch Revealia cancer screening test (noninvasive cheek swab) to DTC market in 2024.
- Intends to apply for OTCQB listing as step toward NASDAQ or CBOE listing.
- Over 3000 mRNA samples collected from 40+ U.S. clinics; uses AI for statistical analysis.

## SEC filing metadata
- accession: 0001903596-24-000495
- form_type: 8-K
- ticker: LUDG
- cik: 0001960262
- company_name: LUDWIG ENTERPRISES, INC.
- filed_at: 2024-08-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.07, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1960262/000190359624000495/0001903596-24-000495-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1960262/000190359624000495/ludg_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001903596-24-000495
- JSON: https://secwatch.observer/filing/0001903596-24-000495.json
- Plain text: https://secwatch.observer/filing/0001903596-24-000495.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.